IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bios Capital Management, LP

Q3 2025 Holdings

Filed 2025-11-12 | 9 holdings | $88.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Actuate Therapeutics Inc(ACTU)COM005083100$67.2M10,049,99675.6%
Cognition Therapeutics Inc(CGTX)COM19243B102$8.1M6,000,0009.1%
Opus Genetics Inc(IRD)COM67577R102$6.6M3,683,4297.4%
Lantern Pharma Inc(LTRN)COM51654W101$4.4M1,015,7155.0%
Rein Therapeutics Inc(RNTX)COM NEW00887A204$1.9M1,690,7512.2%
In8bio IncCOM45674E109$622.1K286,6640.7%